A carregar...
Alzheimer's drug-development pipeline: 2016
BACKGROUND: Alzheimer's disease (AD) is growing in frequency and new therapies are urgently needed. METHODS: We assessed clinicaltrials.gov (accessed 1-4-2016) to determine the number and characteristics of trials in phase I, phase II, and phase III for treatment of AD. RESULTS: There are curre...
Na minha lista:
| Publicado no: | Alzheimers Dement (N Y) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5651348/ https://ncbi.nlm.nih.gov/pubmed/29067309 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2016.07.001 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|